BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6147423)

  • 1. Urodynamic findings and long-term outcome management of patients with multiple sclerosis-induced lower urinary tract dysfunction.
    McGuire EJ; Savastano JA
    J Urol; 1984 Oct; 132(4):713-5. PubMed ID: 6147423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Help for patients with multiple sclerosis: current diagnostic and treatment possibilities in neurogenic disorders of bladder emptying].
    Zwergel U; Wullich B; Jost WH; Zwergel T
    Dtsch Med Wochenschr; 1998 May; 123(22):707-12. PubMed ID: 9645188
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia.
    Kasabian NG; Vlachiotis JD; Lais A; Klumpp B; Kelly MD; Siroky MB; Bauer SB
    J Urol; 1994 Apr; 151(4):944-5. PubMed ID: 8126833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis and the neurogenic bladder.
    Rashid TM; Hollander JB
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):615-29. PubMed ID: 9894113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urodynamics and multiple sclerosis.
    Hinson JL; Boone TB
    Urol Clin North Am; 1996 Aug; 23(3):475-81. PubMed ID: 8701560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The overactive bladder in multiple sclerosis.
    Fingerman JS; Finkelstein LH
    J Am Osteopath Assoc; 2000 Mar; 100(3 Suppl):S9-12. PubMed ID: 10763312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal cord injury in children: long-term urodynamic and urological outcomes.
    Generao SE; Dall'era JP; Stone AR; Kurzrock EA
    J Urol; 2004 Sep; 172(3):1092-4, discussion 1094. PubMed ID: 15311046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urodynamic evaluation in primary enuresis: an investigative and treatment outcome correlation.
    Sehgal R; Paul P; Mohanty NK
    J Trop Pediatr; 2007 Aug; 53(4):259-63. PubMed ID: 17496326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of neurogenic bladder in patients with multiple sclerosis.
    Phé V; Chartier-Kastler E; Panicker JN
    Nat Rev Urol; 2016 May; 13(5):275-88. PubMed ID: 27030526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis-related neurogenic bladder dysfunction.
    Kabay S; Kabay SC; Yucel M; Ozden H; Yilmaz Z; Aras O; Aras B
    Neurourol Urodyn; 2009; 28(8):964-8. PubMed ID: 19373898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder management in multiple sclerosis.
    Yang CC
    Phys Med Rehabil Clin N Am; 2013 Nov; 24(4):673-86. PubMed ID: 24314685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and management of the urologic consequences of neurologic disease.
    Kotkin L; Milam DF
    Tech Urol; 1996; 2(4):210-9. PubMed ID: 9085542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury.
    O'Leary M; Erickson JR; Smith CP; McDermott C; Horton J; Chancellor MB
    J Spinal Cord Med; 2003; 26(2):159-62. PubMed ID: 12828295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genitourinary changes in multiple sclerosis: the need for a urodynamic study].
    Martín C; Salinas J; Fernández-Durán A; Fernández-Gómez J; Jiménez N; Gangoiti L
    Rev Neurol; 2000 Apr 1-15; 30(7):643-8. PubMed ID: 10859743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical findings of neurogenic bladder in patients with Parkinson's disease, multiple sclerosis and spinocerebellar degeneration].
    Shimizu K; Yasukawa M; Yamamoto M; Hirao Y; Momose H; Kashiwai H; Kawata Y; Yamada K
    Hinyokika Kiyo; 1997 Nov; 43(11):765-9. PubMed ID: 9436018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary management of the neurogenic bladder for multiple sclerosis patients.
    Stoffel JT
    Urol Clin North Am; 2010 Nov; 37(4):547-57. PubMed ID: 20955906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The artificial somato-autonomic reflex arch does not improve lower urinary tract function in patients with spinal cord lesions.
    Rasmussen MM; Rawashdeh YF; Clemmensen D; Tankisi H; Fuglsang-Frederiksen A; Krogh K; Christensen P
    J Urol; 2015 Feb; 193(2):598-604. PubMed ID: 25158270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Symptomatic therapy of bladder hyporeflexia in patients with multiple sclerosis].
    Stankovich EIu; Ovcharov VV; Gol'tsova NV; Klimov IuA; Afonin DV; Zolotova SN; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7 Suppl 2):135-7. PubMed ID: 19891358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High EDSS can predict risk for upper urinary tract damage in patients with multiple sclerosis.
    Ineichen BV; Schneider MP; Hlavica M; Hagenbuch N; Linnebank M; Kessler TM
    Mult Scler; 2018 Apr; 24(4):529-534. PubMed ID: 28367674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detrusor Acontractility after Acute Spinal Cord Injury-Myth or Reality?
    Bywater M; Tornic J; Mehnert U; Kessler TM
    J Urol; 2018 Jun; 199(6):1565-1570. PubMed ID: 29352989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.